Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.36 USD | -4.23% | -9.42% | -32.80% |
May. 13 | HC Wainwright Adjusts Price Target on Verona Pharma to $30 From $32, Maintains Buy Rating | MT |
May. 09 | Verona Pharma Signs Financing Agreements for Up to $650 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.80% | 1.08B | |
+8.29% | 114B | |
+10.21% | 104B | |
-0.20% | 22.28B | |
-11.90% | 22.41B | |
-4.64% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- VRNA Stock
- News Verona Pharma plc
- Wedbush Lowers Verona Pharma's Price Target to $23 From $27 Due to Increased Share Count, Keeps Outperform Rating